抗生素 → flora disrupt → C. diff 增殖 → toxin → colitis; 2024 IDSA + ACG 大幅改寫: fidaxomicin 第一線; bezlotoxumab (anti-toxin B mAb) 預防復發; FMT / live biotherapeutic for relapse。